Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Journal of the American College of Cardiology|March 12, 2025
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid CardiomyopathyDaniel P Judge, Kevin M Alexander, Francesco Cappelli, et al.ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 30, 2022
Effects of Body Mass Index on Presentation and Outcomes of COVID-19 among Heart Transplant and Left Ventricular Assist Device Patients: A Multi-Institutional StudyAmit Iyengar, William Cohen, Jason Han, et al.Journal of the American College of Cardiology|October 27, 2025
Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis From ATTRibute-CMAhmad Masri, Daniel P Judge, Frederick L Ruberg, et al.Journal of the American College of Cardiology|May 21, 2025
Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid CardiomyopathyMathew S Maurer, Daniel P Judge, Julian D Gillmore, et al.JAMA Cardiology|March 30, 2026
Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical TrialPrem Soman, Sarah A M Cuddy, Julian D Gillmore, et al.Circulation|November 18, 2024
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM TrialDaniel P Judge, Julian D Gillmore, Kevin M Alexander, et al.JAMA Cardiology|November 8, 2025
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label ExtensionKevin M Alexander, Margot K Davis, Olakunle Akinboboye, et al.Circulation. Heart Failure|April 5, 2021
Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device SupportEdo Y Birati, Samer S Najjar, Ryan J Tedford, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 18, 2021
Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomesMichael V Genuardi, Noah Moss, Samer S Najjar, et al.JACC. Cardiovascular Imaging|February 22, 2025
Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis: Proceedings of the Amyloidosis ForumSharmila Dorbala, Rosalyn Adigun, Kevin M Alexander, et al.Pageof 9